176 EL HEGAZ STREET HELIOPOLIS, CAIRO, EGYPT

Business Strategy

GLOBE’S BUSINESS GOAL IS TO BE ONE OF THE TOP EGYPTIAN PHARMACEUTICAL COMPANIES

OUR MISSION.

Globe creates a difference in lives of people globally through innovation and passion. We aspire to be recognized by our customers, employees and shareholders as the best value pharmaceutical supplier. Globe’s mission We are committed to providing the best solution for unmet challenges within the healthcare system by supplying products of outstanding value to our customers in diversified therapeutic areas.

WHAT WE DO.

Globe is committed to providing the best solution for unmet challenges within the healthcare system by supplying products of outstanding value to our customers in diversified therapeutic areas

GLOBAL STRATEGY

Globe’s business goal is to be one of the top Egyptian pharmaceutical companies. In order to achieve this, Globe through partnership with world-class pharmaceuticals and medical companies has succeeded to deliver unique products' portfolio and also focus to increase the momentum in the branded generics' business in its key market through different growth routes. Growth is targeted for both developed and emerging markets. It is Globe's constant Endeavour to provide a wide basket of generic and innovator products with the aim of achieving customer satisfaction which is fundamental to our business thus providing products and services of the highest quality and consequently ensuring profitable growth and enhancing the wealth of the shareholders.

ACHIEVEMENTS

In 2018 Globe has achieved 15 Million USD$ and our future upcoming plan to have twenty percent growth within the current portfolio. Globe managed to be in the top 100 pharmaceutical companies in Egypt. During 2019 we will launch 4 new products and we are planning to penetrate many different countries in Africa & ME by 2020.

GROWTH STRATEGY

Currently we are focusing on therapeutic segments that embraces both chronic treatment segments, primarily driven by horizontal and vertical expansion in the Egyptian market in addition to partnership with multinational pharmaceutical and medical products.